<strong>Versatile</strong>: Useful at any stage of your cancer care journey.
<strong>Effective for Early Detection</strong>: Suitable for tumours not visible in imaging.

Pinaka

Non-Invasive Test to Guide Cancer Treatment Decisions

Identifies Key Tumour Biomarkers From Blood to Personalise Cancer Therapy

Click to view Pinaka FAQs.

What is Pinaka?

Pinaka is a cutting-edge and non-invasive blood test that provides important information to guide cancer treatment. It works with just a quick and simple blood draw, making it safe and convenient.

This test detects Circulating Tumour Cells (CTCs)-cancer cells that break away from a tumour and enter the bloodstream. Pinaka isolates and identifies these cells using a process called immunocytochemistry (ICC) and further analyses key biomarkers on the CTCs through ICC.

With its highly accurate technology, Pinaka minimises false results, ensuring reliable information. This test can help your doctor identify the right anti-cancer treatments for you, offering a more tailored and personalised approach to your care.

How does it work?

With just a simple blood draw, Pinaka isolates Circulating Tumour Cells (CTCs) and analyses important biomarkers. Using advanced and proven technology, Pinaka can detect CTCs in a wide range of cancer types, regardless of your age, gender, cancer stage, or treatment history. Because CTCs come directly from the tumour, their analysis provides information similar to traditional tumour tissue testing. Studies have shown that biomarker results from CTCs closely match those from tumour tissues, making Pinaka a reliable and effective tool for cancer care.

Why choose Pinaka?

If it is hard to get enough tumour tissue for testing, Pinaka offers a safe and simple alternative. With just a blood test, Pinaka can provide accurate results, even when tissue samples are not available or unclear. Its advanced technology detects Circulating Tumour Cells (CTCs) with high accuracy, giving reliable information to help guide your treatment plan.

Key benefits:

  • Non-Invasive: Safe, convenient, and patient-friendly approach.
  • Reliable Alternative: Effective when tissue-based biomarker analysis is unavailable or inconclusive.
  • Accessible: No need for hospitalisation or visits to advanced healthcare facilities.
  • Risk-Free: Eliminates risks of pain, bleeding, and infection.
  • Versatile: Useful at any stage of your cancer care journey.
  • Effective for Early Detection: Suitable for tumours not visible in imaging.
  • Consistent Results: Not impacted by differences between tumours.